Urticaria laboratory findings: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Urticaria}}
{{Urticaria}}
{{CMG}}
{{CMG}} ; {{AE}} {{Anahita}}


==Overview==
==Overview==
Laboratory evaluation can be used as a measure to determine [[disease]] severity, responsiveness to [[treatment]] and [[prognosis]], in addition to their role as a [[diagnosis|diagnostic tool]]. Tests such as autologous [[serum]] [[skin]] test (ASST) and [[Basophil granulocyte|basophil]] activation test (BAT) are useful for detection of [[Autoantibody|autoantibodies]] against [[Immunoglobulin E|IgE]]. Moreover elevated levels of [[c-reactive protein]] ([[C-reactive protein|CRP]]), [[erythrocyte sedimentation rate]] ([[Erythrocyte sedimentation rate|ESR]]), certain [[interleukins]] and [[tumor necrosis factor-alpha]] have been reported in [[urticaria]] [[patients]]. Laboratory evaluations that can determine [[disease]] activity are autologous [[serum]] [[skin]] test (ASST), [[c-reactive protein]] ([[C-reactive protein|CRP]]) and [[Interleukin 6|IL-6]].


==Laboratory Findings==
==Laboratory Findings==
*Autologous [[serum]] [[skin]] test (ASST) and [[Basophil granulocyte|basophil]] activation test (BAT) are two tests that are capable of detecting any [[Autoantibody|autoantibodies]] against [[Immunoglobulin E|IgE]] for FcεRI.<ref name="pmid31571935">{{cite journal| author=Puxeddu I, Petrelli F, Angelotti F, Croia C, Migliorini P| title=Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications. | journal=J Asthma Allergy | year= 2019 | volume= 12 | issue=  | pages= 285-295 | pmid=31571935 | doi=10.2147/JAA.S184986 | pmc=6759208 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31571935  }} </ref><ref name="pmid26739404">{{cite journal| author=Ye YM, Park JW, Kim SH, Ban GY, Kim JH, Shin YS | display-authors=etal| title=Prognostic Factors for Chronic Spontaneous Urticaria: A 6-Month Prospective Observational Study. | journal=Allergy Asthma Immunol Res | year= 2016 | volume= 8 | issue= 2 | pages= 115-23 | pmid=26739404 | doi=10.4168/aair.2016.8.2.115 | pmc=4713874 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26739404  }} </ref>  
*Autologous [[serum]] [[skin]] test (ASST) and [[Basophil granulocyte|basophil]] activation test (BAT) are two tests that are capable of detecting any [[Autoantibody|autoantibodies]] against [[Immunoglobulin E|IgE]] for FcεRI.<ref name="pmid31571935">{{cite journal| author=Puxeddu I, Petrelli F, Angelotti F, Croia C, Migliorini P| title=Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications. | journal=J Asthma Allergy | year= 2019 | volume= 12 | issue=  | pages= 285-295 | pmid=31571935 | doi=10.2147/JAA.S184986 | pmc=6759208 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31571935  }} </ref><ref name="pmid26739404">{{cite journal| author=Ye YM, Park JW, Kim SH, Ban GY, Kim JH, Shin YS | display-authors=etal| title=Prognostic Factors for Chronic Spontaneous Urticaria: A 6-Month Prospective Observational Study. | journal=Allergy Asthma Immunol Res | year= 2016 | volume= 8 | issue= 2 | pages= 115-23 | pmid=26739404 | doi=10.4168/aair.2016.8.2.115 | pmc=4713874 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26739404  }} </ref>  
**Although ASST is not a [[Specificity (tests)|specific test]], positive results can determine active [[disease]], [[mast cells]] and [[Basophil granulocyte|basophils]] activation and possible reduction in [[Basophil granulocyte|basophils]].  
**Although ASST is not a [[Specificity (tests)|specific test]], positive results can determine active [[disease]], [[mast cells]] and [[Basophil granulocyte|basophils]] activation and possible reduction in [[Basophil granulocyte|basophils]].
**Interestingly positive autologous [[serum]] [[skin]] test (ASST) could be related to better [[prognosis]].  
**Interestingly positive autologous [[serum]] [[skin]] test (ASST) could be related to better [[prognosis]].
**Moreover positive autologous [[serum]] [[skin]] test (ASST) seems to be related to slower response to [[omalizumab]].  
**Moreover positive autologous [[serum]] [[skin]] test (ASST) seems to be related to slower response to [[omalizumab]].
*[[C-reactive protein]] ([[C-reactive protein|CRP]]) is also related to [[disease]] activity and [[treatment]] response in [[urticaria]].<ref name="pmid29130488">{{cite journal| author=Kolkhir P, Altrichter S, Hawro T, Maurer M| title=C-reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria. | journal=Allergy | year= 2018 | volume= 73 | issue= 4 | pages= 940-948 | pmid=29130488 | doi=10.1111/all.13352 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29130488  }} </ref><ref name="pmid21645137">{{cite journal| author=Kasperska-Zajac A, Sztylc J, Machura E, Jop G| title=Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients. | journal=Clin Exp Allergy | year= 2011 | volume= 41 | issue= 10 | pages= 1386-91 | pmid=21645137 | doi=10.1111/j.1365-2222.2011.03789.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21645137  }} </ref><ref name="pmid20534097">{{cite journal| author=Ohtsuka T| title=Response to oral cyclosporine therapy and high sensitivity-CRP level in chronic idiopathic urticaria. | journal=Int J Dermatol | year= 2010 | volume= 49 | issue= 5 | pages= 579-84 | pmid=20534097 | doi=10.1111/j.1365-4632.2010.04384.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20534097  }} </ref>
*[[C-reactive protein]] ([[C-reactive protein|CRP]]) is also related to [[disease]] activity and [[treatment]] response in [[urticaria]].<ref name="pmid29130488">{{cite journal| author=Kolkhir P, Altrichter S, Hawro T, Maurer M| title=C-reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria. | journal=Allergy | year= 2018 | volume= 73 | issue= 4 | pages= 940-948 | pmid=29130488 | doi=10.1111/all.13352 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29130488  }} </ref><ref name="pmid21645137">{{cite journal| author=Kasperska-Zajac A, Sztylc J, Machura E, Jop G| title=Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients. | journal=Clin Exp Allergy | year= 2011 | volume= 41 | issue= 10 | pages= 1386-91 | pmid=21645137 | doi=10.1111/j.1365-2222.2011.03789.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21645137  }} </ref><ref name="pmid20534097">{{cite journal| author=Ohtsuka T| title=Response to oral cyclosporine therapy and high sensitivity-CRP level in chronic idiopathic urticaria. | journal=Int J Dermatol | year= 2010 | volume= 49 | issue= 5 | pages= 579-84 | pmid=20534097 | doi=10.1111/j.1365-4632.2010.04384.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20534097  }} </ref>
**It's elevated level is also associated with positive autologous [[serum]] [[skin]] test (ASST) and elevated levels of [[erythrocyte sedimentation rate]] ([[erythrocyte sedimentation rate|ESR]]), [[White blood cells|leukocytes]], [[neutrophils]] and [[Interleukin 6|IL-6]].
**It's elevated level is also associated with positive autologous [[serum]] [[skin]] test (ASST) and elevated levels of [[erythrocyte sedimentation rate]] ([[erythrocyte sedimentation rate|ESR]]), [[White blood cells|leukocytes]], [[neutrophils]] and [[Interleukin 6|IL-6]].
**Elevated [[C-reactive protein|CRP]] is related to better response to [[mouth|oral]] [[cyclosporine]] [[therapy]] and conversely poor response to [[antihistamines]].  
**Elevated [[C-reactive protein|CRP]] is related to better response to [[mouth|oral]] [[cyclosporine]] [[therapy]] and conversely poor response to [[antihistamines]].
**In contrast to other [[inflammation|inflammatory conditions]], [[urticaria]] [[patients]] usually present with lower quantitative level of [[C-reactive protein|CRP]].  
**In contrast to other [[inflammation|inflammatory conditions]], [[urticaria]] [[patients]] usually present with lower quantitative level of [[C-reactive protein|CRP]].
*[[Complete blood count]] ([[Complete blood count|CBC]]) with differential<ref name="pmid28913986">{{cite journal| author=Kaplan AP| title=Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations. | journal=Allergy Asthma Immunol Res | year= 2017 | volume= 9 | issue= 6 | pages= 477-482 | pmid=28913986 | doi=10.4168/aair.2017.9.6.477 | pmc=5603475 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28913986  }} </ref>
*[[Complete blood count]] ([[Complete blood count|CBC]]) with differential<ref name="pmid28913986">{{cite journal| author=Kaplan AP| title=Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations. | journal=Allergy Asthma Immunol Res | year= 2017 | volume= 9 | issue= 6 | pages= 477-482 | pmid=28913986 | doi=10.4168/aair.2017.9.6.477 | pmc=5603475 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28913986  }} </ref>
*[[Erythrocyte sedimentation rate]] ([[Erythrocyte sedimentation rate|ESR]]): Elevated levels might be related to [[autoimmune disease]].<ref name="pmid28913986">{{cite journal| author=Kaplan AP| title=Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations. | journal=Allergy Asthma Immunol Res | year= 2017 | volume= 9 | issue= 6 | pages= 477-482 | pmid=28913986 | doi=10.4168/aair.2017.9.6.477 | pmc=5603475 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28913986  }} </ref>
*[[Erythrocyte sedimentation rate]] ([[Erythrocyte sedimentation rate|ESR]]): Elevated levels might be related to [[autoimmune disease]].<ref name="pmid28913986">{{cite journal| author=Kaplan AP| title=Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations. | journal=Allergy Asthma Immunol Res | year= 2017 | volume= 9 | issue= 6 | pages= 477-482 | pmid=28913986 | doi=10.4168/aair.2017.9.6.477 | pmc=5603475 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28913986  }} </ref>
Line 20: Line 22:
**[[Interleukin 18|IL-18]], one of the [[Interleukin 1|IL-1 family cytokines]], has been present in [[serum]] specimens of nearly all [[patients]] with [[urticaria|chronic spontaneous urticaria]]. Nevertheless more studies required to determine it's exact role in the [[pathogenesis]] of this subtype.<ref name="pmid17509061">{{cite journal| author=Tedeschi A, Lorini M, Suli C, Asero R| title=Serum interleukin-18 in patients with chronic ordinary urticaria: association with disease activity. | journal=Clin Exp Dermatol | year= 2007 | volume= 32 | issue= 5 | pages= 568-70 | pmid=17509061 | doi=10.1111/j.1365-2230.2007.02450.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17509061  }} </ref><ref name="pmid23433789">{{cite journal| author=Puxeddu I, Italiani P, Giungato P, Pratesi F, Panza F, Bartaloni D | display-authors=etal| title=Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria. | journal=Cytokine | year= 2013 | volume= 61 | issue= 3 | pages= 741-3 | pmid=23433789 | doi=10.1016/j.cyto.2013.01.015 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23433789  }} </ref>
**[[Interleukin 18|IL-18]], one of the [[Interleukin 1|IL-1 family cytokines]], has been present in [[serum]] specimens of nearly all [[patients]] with [[urticaria|chronic spontaneous urticaria]]. Nevertheless more studies required to determine it's exact role in the [[pathogenesis]] of this subtype.<ref name="pmid17509061">{{cite journal| author=Tedeschi A, Lorini M, Suli C, Asero R| title=Serum interleukin-18 in patients with chronic ordinary urticaria: association with disease activity. | journal=Clin Exp Dermatol | year= 2007 | volume= 32 | issue= 5 | pages= 568-70 | pmid=17509061 | doi=10.1111/j.1365-2230.2007.02450.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17509061  }} </ref><ref name="pmid23433789">{{cite journal| author=Puxeddu I, Italiani P, Giungato P, Pratesi F, Panza F, Bartaloni D | display-authors=etal| title=Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria. | journal=Cytokine | year= 2013 | volume= 61 | issue= 3 | pages= 741-3 | pmid=23433789 | doi=10.1016/j.cyto.2013.01.015 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23433789  }} </ref>
**The following table is a summary of possible elevated [[interleukins]] in [[urticaria]]:<ref name="pmid23433789">{{cite journal| author=Puxeddu I, Italiani P, Giungato P, Pratesi F, Panza F, Bartaloni D | display-authors=etal| title=Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria. | journal=Cytokine | year= 2013 | volume= 61 | issue= 3 | pages= 741-3 | pmid=23433789 | doi=10.1016/j.cyto.2013.01.015 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23433789  }} </ref><ref name="pmid31571935">{{cite journal| author=Puxeddu I, Petrelli F, Angelotti F, Croia C, Migliorini P| title=Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications. | journal=J Asthma Allergy | year= 2019 | volume= 12 | issue=  | pages= 285-295 | pmid=31571935 | doi=10.2147/JAA.S184986 | pmc=6759208 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31571935  }} </ref><ref name="pmid27926978">{{cite journal| author=Kolkhir P, André F, Church MK, Maurer M, Metz M| title=Potential blood biomarkers in chronic spontaneous urticaria. | journal=Clin Exp Allergy | year= 2017 | volume= 47 | issue= 1 | pages= 19-36 | pmid=27926978 | doi=10.1111/cea.12870 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27926978  }} </ref>
**The following table is a summary of possible elevated [[interleukins]] in [[urticaria]]:<ref name="pmid23433789">{{cite journal| author=Puxeddu I, Italiani P, Giungato P, Pratesi F, Panza F, Bartaloni D | display-authors=etal| title=Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria. | journal=Cytokine | year= 2013 | volume= 61 | issue= 3 | pages= 741-3 | pmid=23433789 | doi=10.1016/j.cyto.2013.01.015 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23433789  }} </ref><ref name="pmid31571935">{{cite journal| author=Puxeddu I, Petrelli F, Angelotti F, Croia C, Migliorini P| title=Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications. | journal=J Asthma Allergy | year= 2019 | volume= 12 | issue=  | pages= 285-295 | pmid=31571935 | doi=10.2147/JAA.S184986 | pmc=6759208 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31571935  }} </ref><ref name="pmid27926978">{{cite journal| author=Kolkhir P, André F, Church MK, Maurer M, Metz M| title=Potential blood biomarkers in chronic spontaneous urticaria. | journal=Clin Exp Allergy | year= 2017 | volume= 47 | issue= 1 | pages= 19-36 | pmid=27926978 | doi=10.1111/cea.12870 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27926978  }} </ref>
<br>
<br>
{| style="border: 2px solid #4479BA; align="left"
{| style="border: 2px solid #4479BA; align=" left"
! style="width: 200px; background: #4479BA;" | {{fontcolor|#FFF|[[Interleukins]]}}
! style="width: 200px; background: #4479BA;" |{{fontcolor|#FFF|[[Interleukins]]}}
! style="width: 400px; background: #4479BA;" | {{fontcolor|#FFF|Explanations}}
! style="width: 400px; background: #4479BA;" |{{fontcolor|#FFF|Explanations}}
|-
|-
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | [[Interleukin 6]]
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |[[Interleukin 6]]
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | <br>
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |<br>
Determines [[disease]] activity
 
* Determines [[disease]] activity.
|-
|-
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | [[Interleukin 1]]
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |[[Interleukin 1]]
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | <br>
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |<br>
Such as [[Interleukin 18]] and [[Interleukin 17]]
 
<br>
* Such as [[Interleukin 18]] and [[Interleukin 17]]. More studies are required.
More studies are required.
|-
|-
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | [[Interleukin|Interleukin 23]]
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |[[Interleukin|Interleukin 23]]
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | <br>
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |<br>
[[Interleukin|Interleukin 23]]/[[Interleukin 17]] axis has been explained in [[pathogenesis]] of [[urticaria]].
 
* [[Interleukin|Interleukin 23]]/[[Interleukin 17]] axis has been explained in the [[pathogenesis]] of [[urticaria]].
|-
|-
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | [[Interleukin 31]]
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |[[Interleukin 31]]
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | <br>
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |
Also elevated in other [[inflammation|chronic skin inflammations]].
* Also elevated in other [[inflammation|chronic skin inflammations]].
<br>
* <br>No association to [[disease]] activity.
No association to [[disease]] activity.
* <br>[[Omalizumab]] [[treatment]] leads to a remarkable reduction in [[interleukin 31]] response and might be used as a predictor of response to [[omalizumab]].
<br>
[[Omalizumab]] [[treatment]] lead to a remarkable reduction in [[interleukin 31]] response and might be used as a predictor of response to [[omalizumab]].  
|-
|-
|}
|}
<br>
<br>
*Elevated levels of [[tumor necrosis factor-alpha]] has been detected in some [[patients]] with [[urticaria|chronic spontaneous urticaria]].
*Elevated levels of [[tumor necrosis factor-alpha]] has been detected in some [[patients]] with [[urticaria|chronic spontaneous urticaria]].
*The following table is a summary of useful markers to determine [[disease]] severity and response to [[treatment]] in [[urticaria]]:<ref name="pmid31571935">{{cite journal| author=Puxeddu I, Petrelli F, Angelotti F, Croia C, Migliorini P| title=Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications. | journal=J Asthma Allergy | year= 2019 | volume= 12 | issue=  | pages= 285-295 | pmid=31571935 | doi=10.2147/JAA.S184986 | pmc=6759208 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31571935  }} </ref><ref name="pmid11764301">{{cite journal| author=Grattan CE| title=Basophils in chronic urticaria. | journal=J Investig Dermatol Symp Proc | year= 2001 | volume= 6 | issue= 2 | pages= 139-40 | pmid=11764301 | doi=10.1046/j.0022-202x.2001.00027.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11764301  }} </ref><ref name="pmid20214668">{{cite journal| author=Tedeschi A, Asero R, Lorini M, Marzano AV, Cugno M| title=Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors. | journal=Clin Exp Allergy | year= 2010 | volume= 40 | issue= 6 | pages= 875-81 | pmid=20214668 | doi=10.1111/j.1365-2222.2010.03473.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20214668  }} </ref><ref name="pmid23451767">{{cite journal| author=Atwa MA, Emara AS, Youssef N, Bayoumy NM| title=Serum concentration of IL-17, IL-23 and TNF-α among patients with chronic spontaneous urticaria: association with disease activity and autologous serum skin test. | journal=J Eur Acad Dermatol Venereol | year= 2014 | volume= 28 | issue= 4 | pages= 469-74 | pmid=23451767 | doi=10.1111/jdv.12124 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23451767  }} </ref><ref name="pmid28299827">{{cite journal| author=Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A, González-Aveledo L, Maurer M| title=Factors linked to disease severity and time to remission in patients with chronic spontaneous urticaria. | journal=J Eur Acad Dermatol Venereol | year= 2017 | volume= 31 | issue= 6 | pages= 964-971 | pmid=28299827 | doi=10.1111/jdv.14221 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28299827  }} </ref><ref name="pmid30584542">{{cite journal| author=Folci M, Heffler E, Canonica GW, Furlan R, Brunetta E| title=Cutting Edge: Biomarkers for Chronic Spontaneous Urticaria. | journal=J Immunol Res | year= 2018 | volume= 2018 | issue=  | pages= 5615109 | pmid=30584542 | doi=10.1155/2018/5615109 | pmc=6280255 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30584542  }} </ref>
*The following table is a summary of useful markers to determine [[disease]] severity and response to [[treatment]] in [[urticaria]]:<ref name="pmid31571935">{{cite journal| author=Puxeddu I, Petrelli F, Angelotti F, Croia C, Migliorini P| title=Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications. | journal=J Asthma Allergy | year= 2019 | volume= 12 | issue=  | pages= 285-295 | pmid=31571935 | doi=10.2147/JAA.S184986 | pmc=6759208 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31571935  }} </ref><ref name="pmid11764301">{{cite journal| author=Grattan CE| title=Basophils in chronic urticaria. | journal=J Investig Dermatol Symp Proc | year= 2001 | volume= 6 | issue= 2 | pages= 139-40 | pmid=11764301 | doi=10.1046/j.0022-202x.2001.00027.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11764301  }} </ref><ref name="pmid20214668">{{cite journal| author=Tedeschi A, Asero R, Lorini M, Marzano AV, Cugno M| title=Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors. | journal=Clin Exp Allergy | year= 2010 | volume= 40 | issue= 6 | pages= 875-81 | pmid=20214668 | doi=10.1111/j.1365-2222.2010.03473.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20214668  }} </ref><ref name="pmid23451767">{{cite journal| author=Atwa MA, Emara AS, Youssef N, Bayoumy NM| title=Serum concentration of IL-17, IL-23 and TNF-α among patients with chronic spontaneous urticaria: association with disease activity and autologous serum skin test. | journal=J Eur Acad Dermatol Venereol | year= 2014 | volume= 28 | issue= 4 | pages= 469-74 | pmid=23451767 | doi=10.1111/jdv.12124 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23451767  }} </ref><ref name="pmid28299827">{{cite journal| author=Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A, González-Aveledo L, Maurer M| title=Factors linked to disease severity and time to remission in patients with chronic spontaneous urticaria. | journal=J Eur Acad Dermatol Venereol | year= 2017 | volume= 31 | issue= 6 | pages= 964-971 | pmid=28299827 | doi=10.1111/jdv.14221 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28299827  }} </ref><ref name="pmid30584542">{{cite journal| author=Folci M, Heffler E, Canonica GW, Furlan R, Brunetta E| title=Cutting Edge: Biomarkers for Chronic Spontaneous Urticaria. | journal=J Immunol Res | year= 2018 | volume= 2018 | issue=  | pages= 5615109 | pmid=30584542 | doi=10.1155/2018/5615109 | pmc=6280255 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30584542  }} </ref>
{| style="border: 2px solid #4479BA; align="left"
 
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Markers to determine [[disease]] severity/[[prognosis]]
{| style="border: 2px solid #4479BA; align=" left"
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | <br>
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |Markers to determine [[disease]] severity/[[prognosis]]
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |<br>
 
*[[Basophil granulocyte|Basophil]] count
*[[Basophil granulocyte|Basophil]] count
*[[Basophil granulocyte|CD203-c basophils]]
*[[Basophil granulocyte|CD203-c basophils]]
Line 71: Line 76:
*[[Glycoprotein 130|Soluble gp130]]
*[[Glycoprotein 130|Soluble gp130]]
|-
|-
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Markers to evaluate response to [[therapy]]
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |Markers to evaluate response to [[therapy]]
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | <br>
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |<br>
 
*[[C-reactive protein|CRP]]
*[[C-reactive protein|CRP]]
*[[Basophil granulocyte|CD203-c basophils]]
*[[Basophil granulocyte|CD203-c basophils]]
Line 82: Line 88:
*Autologous [[serum]] [[skin]] test (ASST)
*Autologous [[serum]] [[skin]] test (ASST)
*[[Basophil granulocyte|Basophil]] [[histamine]] release assay (BHRA)
*[[Basophil granulocyte|Basophil]] [[histamine]] release assay (BHRA)
*[[Immunoglobulin E]]  
*[[Immunoglobulin E]]
*[[Clusterin]]
*[[Clusterin]]
|-
|-
|}
|}
<br>
<br>
*High levels of [[vascular endothelial growth factor]] ([[Vascular endothelial growth factor|VEGF]]) has been detected in [[urticaria]] [[patients]], which is probably related to it's effect on [[vascular permeability]].
*High levels of [[vascular endothelial growth factor]] ([[Vascular endothelial growth factor|VEGF]]) has been detected in [[urticaria]] [[patients]], which is probably related to it's effect on [[vascular permeability]].
*It is recommended to search for [[paraproteins]], [[hepatitis B]], [[hepatitis C]], [[systemic lupus erythematosus]] and [[inflammatory bowel disease]] in [[patients]] with confirmed [[diagnosis]] of [[urticaria vasculitis]].<ref name="pmid10756214">{{cite journal| author=Greaves M| title=Chronic urticaria. | journal=J Allergy Clin Immunol | year= 2000 | volume= 105 | issue= 4 | pages= 664-72 | pmid=10756214 | doi=10.1067/mai.2000.105706 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10756214  }} </ref>
*It is recommended to search for [[paraproteins]], [[hepatitis B]], [[hepatitis C]], [[systemic lupus erythematosus]] and [[inflammatory bowel disease]] in [[patients]] with confirmed [[diagnosis]] of [[urticaria|urticaria vasculitis]].<ref name="pmid10756214">{{cite journal| author=Greaves M| title=Chronic urticaria. | journal=J Allergy Clin Immunol | year= 2000 | volume= 105 | issue= 4 | pages= 664-72 | pmid=10756214 | doi=10.1067/mai.2000.105706 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10756214  }} </ref>


==References==
==References==
Line 94: Line 101:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Needs content]]
[[Category:Dermatology]]
[[Category:Dermatology]]
[[Category:Allergology]]
[[Category:Allergology]]
[[Category:Immunology]]
[[Category:Immunology]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Disease]]

Latest revision as of 16:10, 4 February 2021

Urticaria Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Urticaria from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Urticaria laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Urticaria laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Urticaria laboratory findings

CDC on Urticaria laboratory findings

Urticaria laboratory findings in the news

Blogs on Urticaria laboratory findings

Directions to Hospitals Treating Urticaria

Risk calculators and risk factors for Urticaria laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Anahita Deylamsalehi, M.D.[2]

Overview

Laboratory evaluation can be used as a measure to determine disease severity, responsiveness to treatment and prognosis, in addition to their role as a diagnostic tool. Tests such as autologous serum skin test (ASST) and basophil activation test (BAT) are useful for detection of autoantibodies against IgE. Moreover elevated levels of c-reactive protein (CRP), erythrocyte sedimentation rate (ESR), certain interleukins and tumor necrosis factor-alpha have been reported in urticaria patients. Laboratory evaluations that can determine disease activity are autologous serum skin test (ASST), c-reactive protein (CRP) and IL-6.

Laboratory Findings


Interleukins Explanations
Interleukin 6
Interleukin 1
Interleukin 23
Interleukin 31


Markers to determine disease severity/prognosis
Markers to evaluate response to therapy


References

  1. ↑ 1.0 1.1 1.2 Puxeddu I, Petrelli F, Angelotti F, Croia C, Migliorini P (2019). "Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications". J Asthma Allergy. 12: 285–295. doi:10.2147/JAA.S184986. PMC 6759208 Check |pmc= value (help). PMID 31571935.
  2. ↑ Ye YM, Park JW, Kim SH, Ban GY, Kim JH, Shin YS; et al. (2016). "Prognostic Factors for Chronic Spontaneous Urticaria: A 6-Month Prospective Observational Study". Allergy Asthma Immunol Res. 8 (2): 115–23. doi:10.4168/aair.2016.8.2.115. PMC 4713874. PMID 26739404.
  3. ↑ Kolkhir P, Altrichter S, Hawro T, Maurer M (2018). "C-reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria". Allergy. 73 (4): 940–948. doi:10.1111/all.13352. PMID 29130488.
  4. ↑ 4.0 4.1 Kasperska-Zajac A, Sztylc J, Machura E, Jop G (2011). "Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients". Clin Exp Allergy. 41 (10): 1386–91. doi:10.1111/j.1365-2222.2011.03789.x. PMID 21645137.
  5. ↑ Ohtsuka T (2010). "Response to oral cyclosporine therapy and high sensitivity-CRP level in chronic idiopathic urticaria". Int J Dermatol. 49 (5): 579–84. doi:10.1111/j.1365-4632.2010.04384.x. PMID 20534097.
  6. ↑ 6.0 6.1 Kaplan AP (2017). "Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations". Allergy Asthma Immunol Res. 9 (6): 477–482. doi:10.4168/aair.2017.9.6.477. PMC 5603475. PMID 28913986.
  7. ↑ Tedeschi A, Lorini M, Suli C, Asero R (2007). "Serum interleukin-18 in patients with chronic ordinary urticaria: association with disease activity". Clin Exp Dermatol. 32 (5): 568–70. doi:10.1111/j.1365-2230.2007.02450.x. PMID 17509061.
  8. ↑ 8.0 8.1 Puxeddu I, Italiani P, Giungato P, Pratesi F, Panza F, Bartaloni D; et al. (2013). "Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria". Cytokine. 61 (3): 741–3. doi:10.1016/j.cyto.2013.01.015. PMID 23433789.
  9. ↑ Kolkhir P, André F, Church MK, Maurer M, Metz M (2017). "Potential blood biomarkers in chronic spontaneous urticaria". Clin Exp Allergy. 47 (1): 19–36. doi:10.1111/cea.12870. PMID 27926978.
  10. ↑ Grattan CE (2001). "Basophils in chronic urticaria". J Investig Dermatol Symp Proc. 6 (2): 139–40. doi:10.1046/j.0022-202x.2001.00027.x. PMID 11764301.
  11. ↑ Tedeschi A, Asero R, Lorini M, Marzano AV, Cugno M (2010). "Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors". Clin Exp Allergy. 40 (6): 875–81. doi:10.1111/j.1365-2222.2010.03473.x. PMID 20214668.
  12. ↑ Atwa MA, Emara AS, Youssef N, Bayoumy NM (2014). "Serum concentration of IL-17, IL-23 and TNF-α among patients with chronic spontaneous urticaria: association with disease activity and autologous serum skin test". J Eur Acad Dermatol Venereol. 28 (4): 469–74. doi:10.1111/jdv.12124. PMID 23451767.
  13. ↑ Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A, González-Aveledo L, Maurer M (2017). "Factors linked to disease severity and time to remission in patients with chronic spontaneous urticaria". J Eur Acad Dermatol Venereol. 31 (6): 964–971. doi:10.1111/jdv.14221. PMID 28299827.
  14. ↑ Folci M, Heffler E, Canonica GW, Furlan R, Brunetta E (2018). "Cutting Edge: Biomarkers for Chronic Spontaneous Urticaria". J Immunol Res. 2018: 5615109. doi:10.1155/2018/5615109. PMC 6280255. PMID 30584542.
  15. ↑ Greaves M (2000). "Chronic urticaria". J Allergy Clin Immunol. 105 (4): 664–72. doi:10.1067/mai.2000.105706. PMID 10756214.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Urticaria_laboratory_findings&oldid=1688590"